XM n’offre pas ses services aux résidents des États-Unis d’Amérique.
G
G

Getinge


Actualités

Getinge's CE Certificate For ECLS Consumables Reinstated

BRIEF-Getinge's CE Certificate For ECLS Consumables Reinstated Sept 25 (Reuters) - Getinge AB GETIb.ST : GETINGE’S CE CERTIFICATE FOR ECLS CONSUMABLES REINSTATED TEMPORARY CHALLENGES RELATED TO NEW PACKAGING SOLUTION RESULTED IN LOWER VOLUME OF HLS AND PLEASE SETS AVAILABLE FOR SHIPMENT IN Q3 2024 TÜV SÜD REINSTATES GETINGE’S CE CERTIFICATE F
G

ASOS, JTC, London Stock Exchange

EUROPE RESEARCH ROUNDUP-ASOS, JTC, London Stock Exchange Sept 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies including ASOS, JTC and London Stock Exchange, on Thursday. HIGHLIGHTS * ASOS Plc ASOS.L : HSBC cuts to reduce from hold * JTC Plc JTC.L : RBC raises target price to 1,100p from 980p * London Stock Exchange LSEG.L : HSBC raises target price to 10,000p from 9,400p * Nordic Semiconductor ASA NOD.OL : Barclays cuts target price to NOK
A
A
A
A
A
A
B
C
E
E
F
G
H
L
N
N
N
S
S
S
T
T
A
A
A
A
N
R

Getinge CEO Buys Shares

BRIEF-Getinge CEO Buys Shares Sept 5(Reuters) - Getinge AB GETIb.ST : SAID ON WEDNESDAY CEO OF GETINGE AB MATTIAS PERJOS BUYS 20,000 SHARES AT PRICE ABOUT SEK 218.0771 PER SHARE ON SEPTEMBER 4TH Source text for Workspace: [ Full Story ] Further company coverage: [GETIb.ST] (Gdansk Newsroom)
G

Getinge Makes A Provision Of MBRL 240 Related To Brazilian Investigation

BRIEF-Getinge Makes A Provision Of MBRL 240 Related To Brazilian Investigation Sept 1 (Reuters) - Getinge AB GETIb.ST : GETINGE MAKES A PROVISION OF MBRL 240 RELATED TO BRAZILIAN INVESTIGATION GETINGE - FINAL AND DEFINITIVE COSTS WILL BE DETERMINED WHEN SETTLEMENT NEGOTIATIONS ARE CONCLUDED GETINGE - PROVISION WILL BE REPORTED AS AN ITEM AFFECTING
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Updates: Schenker Aug 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Friday: ** Deutsche Bahn's logistics unit Schenker has received final bids from Danish transport firm DSV DSV.CO and a consortium led by CVC Capital Partners CVC.AS , with each valuing the business at around 14 billion euros ($15.6 billion), two people familiar with the matter told Reuters.
G

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Aug 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Friday: ** Deutsche Bahn's logistics unit Schenker has collected final bids from a consortium led by CVC Capital Partners CVC.AS and Danish transport firm DSV DSV.CO that value the business at around 14 billion euros ($15.57 billion), two people familiar with the matter told Reuters.
G

Paragonix Technologies Signs Definitive Agreement To Be Acquired By Getinge

BRIEF-Paragonix Technologies Signs Definitive Agreement To Be Acquired By Getinge Aug 22 (Reuters) - Getinge AB GETIb.ST : PARAGONIX TECHNOLOGIES SIGNS DEFINITIVE AGREEMENT TO BE ACQUIRED BY GETINGE Source text for Eikon: ID:nBw6XvskYa Further company coverage: [GETIb.ST]
G

Getinge To Acquire Paragonix Technologies

BRIEF-Getinge To Acquire Paragonix Technologies Aug 22 (Reuters) - Getinge AB GETIb.ST : GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET GETINGE- PROPOSED DEAL FOR APPROXIMATELY USD 477 MILLION. Source text for Eikon: ID:nPnblMm1na Further company coverage: [GETIb.ST]
G

Swedish firm Getinge to buy Paragonix Technologies for about $477 mln

Swedish firm Getinge to buy Paragonix Technologies for about $477 mln Aug 22 (Reuters) - Swedish medical-equipment maker Getinge GETIb.ST said on Thursday it will acquire U.S.-based organ transport company Paragonix Technologies for about $477 million. Getinge will acquire all the issued and outstanding shares of the privately-held Paragonix on a cash and debt-free basis, adding that the initial payout related to the acquisition will be financed through a bridge loan provided by Swedish bank SEB
G

Getinge Says Co To Acquire Paragonix Technologies For USD 477 Mln

BRIEF-Getinge Says Co To Acquire Paragonix Technologies For USD 477 Mln Aug 22 (Reuters) - Getinge AB GETIb.ST : GETINGE TO ACQUIRE PARAGONIX TECHNOLOGIES, A GROWTH LEADER IN THE ORGAN TRANSPLANTATION MARKET GETINGE AB - ACQUIRES PARAGONIX TECHNOLOGIES FOR USD 477 MILLION GETINGE - AGGREGATED UPFRONT PURCHASE PRICE OF $477 MILLION, OF WHICH USD 253
G

Anglo American, Rio Tinto, Unilever

EUROPE RESEARCH ROUNDUP-Anglo American, Rio Tinto, Unilever July 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Anglo American, Rio Tinto and Unilever, on Tuesday. HIGHLIGHTS * Anglo American Plc AAL.L : HSBC cuts target price to 2,300p from 2,450p * Antofagasta Plc ANTO.L : HSBC raises target price to 1,400p from 1,100p * Belimo Holding AG BEAN.S : Jefferies raises target price to CHF 598 from CHF 498 * Rio Tinto RIO.L : HSBC
A
A
A
B
B
D
E
F
G
G
G
P
T
W
A
A
B
G
R

Barclays, Mips AB, Novo Nordisk

EUROPE RESEARCH ROUNDUP-Barclays, Mips AB, Novo Nordisk July 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Barclays, Mips AB and Novo Nordisk on Friday. HIGHLIGHTS * Barclays BARC.L : Jefferies raises target price to 341p from 335p * Mips AB MIPS.ST : Jefferies raises to buy from hold * Novo Nordisk NOVOB.CO : HSBC raises target price to DKK 1150 from DKK 1030 * Spectris SXS.L : HSBC raises target price to 3750p from 3425p * S
A
A
B
B
B
B
B
C
D
E
E
E
G
H
H
H
K
S
S
S
T
A
A

European shares end marginally lower as tech sell-off stymies advances

UPDATE 3-European shares end marginally lower as tech sell-off stymies advances For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window STOXX 600 closes down 0.2% ECB keeps rates unchanged at 3.75% Volvo Cars rise on Q2 adjusted EBIT beat Husqvarna slides on Q2 sales drop Updated at 1600 GMT By Shristi Achar A, Pranav Kashyap and Shashwat Chauhan July 18 (Reuters) - European shares ended lower on Thursday as a continued selloff of chip stocks ke
A
G
H
N
V
E
F
S
G

Getinge rises after Q2 earnings beat

BUZZ-Getinge rises after Q2 earnings beat ** Shares in Getinge GETIb.ST rise around 7% after the Swedish medical equipment maker's Q2 earnings beat expectations ** EBITA, adjusted for items affecting comparability, came in at 981 million Swedish crowns ($93 million) vs analysts' expectations of 829 million crowns ** Group sales came in 4.7% ahead o
G

Medical gear maker Getinge tops Q2 profit forecast as orders grow

UPDATE 3-Medical firm Getinge jumps as rising orders fuel profit beat Adds share move in paragraph 2, analyst comment in -7 By Greta Rosen Fondahn July 18 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST beat second-quarter earnings forecasts on Thursday as its order intake rose despite some problems with its packaging and heart products.
G

Medical gear maker Getinge beats Q2 core profit expectations

Medical gear maker Getinge beats Q2 core profit expectations July 18 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST reported bigger-than-expected core earnings for the second quarter on Thursday, as its order intake grew organically in the period. Reporting by Greta Rosen Fondahn in Gdansk; editing by Milla Nissi
G

Nordic corporate earnings week ahead

DIARY-Nordic corporate earnings week ahead July 12 (Reuters) - Diary of Nordic (OMXS30-SK, OBX-OS, OMXHPI-HE, OMXC20) corporate earnings for the week ahead NORDIC EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 15-Jul-2024 NTS ORK.OL Orkla ASA Q2 2024 Orkla ASA Earnings Release 17-Jul-2024 05:00 NEL.OL Nel ASA Q2 2024 Nel ASA Earnings Release 18-Jul-2024 NTS TEL.OL Telenor ASA Q2 2024 Telenor ASA Earnings Release 18-Jul-2024 NTS PGS.OL^G24 5088687729 PGS ASA Tgs Newco AS Q2 2024
A
B
D
E
E
E
G
K
K
N
O
P
S
S
T
T
V
W
A
A
S
T
Y



Conditions

Actifs populaires

Avertissement : Les entités de XM Group proposent à notre plateforme de trading en ligne un service d'exécution uniquement, autorisant une personne à consulter et/ou à utiliser le contenu disponible sur ou via le site internet, qui n'a pas pour but de modifier ou d'élargir cette situation. De tels accès et utilisation sont toujours soumis aux : (i) Conditions générales ; (ii) Avertissements sur les risques et (iii) Avertissement complet. Un tel contenu n'est par conséquent fourni que pour information générale. En particulier, sachez que les contenus de notre plateforme de trading en ligne ne sont ni une sollicitation ni une offre de participation à toute transaction sur les marchés financiers. Le trading sur les marchés financiers implique un niveau significatif de risques pour votre capital.

Tout le matériel publié dans notre Centre de trading en ligne est destiné à des fins de formation / d'information uniquement et ne contient pas – et ne doit pas être considéré comme contenant – des conseils et recommandations en matière de finance, de fiscalité des investissements ou de trading, ou un enregistrement de nos prix de trading ou une offre, une sollicitation, une transaction à propos de tout instrument financier ou bien des promotions financières non sollicitées à votre égard.

Tout contenu tiers, de même que le contenu préparé par XM, tels que les opinions, actualités, études, analyses, prix, autres informations ou liens vers des sites tiers contenus sur ce site internet sont fournis "tels quels", comme commentaires généraux sur le marché et ne constituent pas des conseils en investissement. Dans la mesure où tout contenu est considéré comme de la recherche en investissement, vous devez noter et accepter que le contenu n'a pas été conçu ni préparé conformément aux exigences légales visant à promouvoir l'indépendance de la recherche en investissement et, en tant que tel, il serait considéré comme une communication marketing selon les lois et réglementations applicables. Veuillez vous assurer que vous avez lu et compris notre Avis sur la recherche en investissement non indépendante et notre avertissement sur les risques concernant les informations susdites, qui peuvent consultés ici.

Avertissement sur les risques : votre capital est à risque. Les produits à effet de levier ne sont pas recommandés pour tous. Veuillez consulter notre Divulgation des risques